Kinase Reaction of Lapatinib (IMAGE)
Caption
When the drug lapatinib inhibits the expression of the HER2 kinase in five different HER2-positive breast cancer cell lines, other kinases are also tamped down (blue) but several more kinases are activated (red), leading to drug resistance and tumor growth.
Credit
Tim Stuhlmiller, PhD, UNC School of Medicine
Usage Restrictions
Credit properly
License
Licensed content